The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Valacyclovir Oral Market Research Report 2023

Global Valacyclovir Oral Market Research Report 2023

Publishing Date : Oct, 2023

License Type :
 

Report Code : 1804411

No of Pages : 102

Synopsis
Valacyclovir is used to treat herpes virus infections, including herpes labialis (also known as cold sores), herpes zoster (also known as shingles), and herpes simplex (also known as genital herpes) in adults. It is also used to treat chickenpox and cold sores in children.
Global Valacyclovir Oral market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Valacyclovir Oral market research.
Key manufacturers engaged in the Valacyclovir Oral industry include GSK, Sandoz, Sun Pharmaceutical, Cipla, Mylan, Teva, Zydus Pharmaceuticals, West-Ward Pharmaceuticals and Time Cap Labs, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Valacyclovir Oral were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Valacyclovir Oral market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Valacyclovir Oral market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
GSK
Sandoz
Sun Pharmaceutical
Cipla
Mylan
Teva
Zydus Pharmaceuticals
West-Ward Pharmaceuticals
Time Cap Labs
Wockhardt
Apotex
Aurobindo Pharma
Jubilant Pharma
Lunan Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Tasly
Segment by Type
500mg Tablet
1000mg Tablet
300mg Tablet
Others
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Valacyclovir Oral report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index
1 Valacyclovir Oral Market Overview
1.1 Product Overview and Scope of Valacyclovir Oral
1.2 Valacyclovir Oral Segment by Type
1.2.1 Global Valacyclovir Oral Market Value Comparison by Type (2023-2029)
1.2.2 500mg Tablet
1.2.3 1000mg Tablet
1.2.4 300mg Tablet
1.2.5 Others
1.3 Valacyclovir Oral Segment by Application
1.3.1 Global Valacyclovir Oral Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Valacyclovir Oral Market Size Estimates and Forecasts
1.4.1 Global Valacyclovir Oral Revenue 2018-2029
1.4.2 Global Valacyclovir Oral Sales 2018-2029
1.4.3 Global Valacyclovir Oral Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Valacyclovir Oral Market Competition by Manufacturers
2.1 Global Valacyclovir Oral Sales Market Share by Manufacturers (2018-2023)
2.2 Global Valacyclovir Oral Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Valacyclovir Oral Average Price by Manufacturers (2018-2023)
2.4 Global Valacyclovir Oral Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Valacyclovir Oral, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Valacyclovir Oral, Product Type & Application
2.7 Valacyclovir Oral Market Competitive Situation and Trends
2.7.1 Valacyclovir Oral Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Valacyclovir Oral Players Market Share by Revenue
2.7.3 Global Valacyclovir Oral Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Valacyclovir Oral Retrospective Market Scenario by Region
3.1 Global Valacyclovir Oral Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Valacyclovir Oral Global Valacyclovir Oral Sales by Region: 2018-2029
3.2.1 Global Valacyclovir Oral Sales by Region: 2018-2023
3.2.2 Global Valacyclovir Oral Sales by Region: 2024-2029
3.3 Global Valacyclovir Oral Global Valacyclovir Oral Revenue by Region: 2018-2029
3.3.1 Global Valacyclovir Oral Revenue by Region: 2018-2023
3.3.2 Global Valacyclovir Oral Revenue by Region: 2024-2029
3.4 North America Valacyclovir Oral Market Facts & Figures by Country
3.4.1 North America Valacyclovir Oral Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Valacyclovir Oral Sales by Country (2018-2029)
3.4.3 North America Valacyclovir Oral Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Valacyclovir Oral Market Facts & Figures by Country
3.5.1 Europe Valacyclovir Oral Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Valacyclovir Oral Sales by Country (2018-2029)
3.5.3 Europe Valacyclovir Oral Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Valacyclovir Oral Market Facts & Figures by Country
3.6.1 Asia Pacific Valacyclovir Oral Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Valacyclovir Oral Sales by Country (2018-2029)
3.6.3 Asia Pacific Valacyclovir Oral Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Valacyclovir Oral Market Facts & Figures by Country
3.7.1 Latin America Valacyclovir Oral Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Valacyclovir Oral Sales by Country (2018-2029)
3.7.3 Latin America Valacyclovir Oral Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Valacyclovir Oral Market Facts & Figures by Country
3.8.1 Middle East and Africa Valacyclovir Oral Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Valacyclovir Oral Sales by Country (2018-2029)
3.8.3 Middle East and Africa Valacyclovir Oral Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Valacyclovir Oral Sales by Type (2018-2029)
4.1.1 Global Valacyclovir Oral Sales by Type (2018-2023)
4.1.2 Global Valacyclovir Oral Sales by Type (2024-2029)
4.1.3 Global Valacyclovir Oral Sales Market Share by Type (2018-2029)
4.2 Global Valacyclovir Oral Revenue by Type (2018-2029)
4.2.1 Global Valacyclovir Oral Revenue by Type (2018-2023)
4.2.2 Global Valacyclovir Oral Revenue by Type (2024-2029)
4.2.3 Global Valacyclovir Oral Revenue Market Share by Type (2018-2029)
4.3 Global Valacyclovir Oral Price by Type (2018-2029)
5 Segment by Application
5.1 Global Valacyclovir Oral Sales by Application (2018-2029)
5.1.1 Global Valacyclovir Oral Sales by Application (2018-2023)
5.1.2 Global Valacyclovir Oral Sales by Application (2024-2029)
5.1.3 Global Valacyclovir Oral Sales Market Share by Application (2018-2029)
5.2 Global Valacyclovir Oral Revenue by Application (2018-2029)
5.2.1 Global Valacyclovir Oral Revenue by Application (2018-2023)
5.2.2 Global Valacyclovir Oral Revenue by Application (2024-2029)
5.2.3 Global Valacyclovir Oral Revenue Market Share by Application (2018-2029)
5.3 Global Valacyclovir Oral Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GSK Valacyclovir Oral Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sandoz
6.2.1 Sandoz Corporation Information
6.2.2 Sandoz Description and Business Overview
6.2.3 Sandoz Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sandoz Valacyclovir Oral Product Portfolio
6.2.5 Sandoz Recent Developments/Updates
6.3 Sun Pharmaceutical
6.3.1 Sun Pharmaceutical Corporation Information
6.3.2 Sun Pharmaceutical Description and Business Overview
6.3.3 Sun Pharmaceutical Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sun Pharmaceutical Valacyclovir Oral Product Portfolio
6.3.5 Sun Pharmaceutical Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Corporation Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cipla Valacyclovir Oral Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Mylan Valacyclovir Oral Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Teva Valacyclovir Oral Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Zydus Pharmaceuticals
6.6.1 Zydus Pharmaceuticals Corporation Information
6.6.2 Zydus Pharmaceuticals Description and Business Overview
6.6.3 Zydus Pharmaceuticals Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zydus Pharmaceuticals Valacyclovir Oral Product Portfolio
6.7.5 Zydus Pharmaceuticals Recent Developments/Updates
6.8 West-Ward Pharmaceuticals
6.8.1 West-Ward Pharmaceuticals Corporation Information
6.8.2 West-Ward Pharmaceuticals Description and Business Overview
6.8.3 West-Ward Pharmaceuticals Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2023)
6.8.4 West-Ward Pharmaceuticals Valacyclovir Oral Product Portfolio
6.8.5 West-Ward Pharmaceuticals Recent Developments/Updates
6.9 Time Cap Labs
6.9.1 Time Cap Labs Corporation Information
6.9.2 Time Cap Labs Description and Business Overview
6.9.3 Time Cap Labs Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Time Cap Labs Valacyclovir Oral Product Portfolio
6.9.5 Time Cap Labs Recent Developments/Updates
6.10 Wockhardt
6.10.1 Wockhardt Corporation Information
6.10.2 Wockhardt Description and Business Overview
6.10.3 Wockhardt Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Wockhardt Valacyclovir Oral Product Portfolio
6.10.5 Wockhardt Recent Developments/Updates
6.11 Apotex
6.11.1 Apotex Corporation Information
6.11.2 Apotex Valacyclovir Oral Description and Business Overview
6.11.3 Apotex Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Apotex Valacyclovir Oral Product Portfolio
6.11.5 Apotex Recent Developments/Updates
6.12 Aurobindo Pharma
6.12.1 Aurobindo Pharma Corporation Information
6.12.2 Aurobindo Pharma Valacyclovir Oral Description and Business Overview
6.12.3 Aurobindo Pharma Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Aurobindo Pharma Valacyclovir Oral Product Portfolio
6.12.5 Aurobindo Pharma Recent Developments/Updates
6.13 Jubilant Pharma
6.13.1 Jubilant Pharma Corporation Information
6.13.2 Jubilant Pharma Valacyclovir Oral Description and Business Overview
6.13.3 Jubilant Pharma Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Jubilant Pharma Valacyclovir Oral Product Portfolio
6.13.5 Jubilant Pharma Recent Developments/Updates
6.14 Lunan Pharmaceutical
6.14.1 Lunan Pharmaceutical Corporation Information
6.14.2 Lunan Pharmaceutical Valacyclovir Oral Description and Business Overview
6.14.3 Lunan Pharmaceutical Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Lunan Pharmaceutical Valacyclovir Oral Product Portfolio
6.14.5 Lunan Pharmaceutical Recent Developments/Updates
6.15 Shandong Luoxin Pharmaceutical Group
6.15.1 Shandong Luoxin Pharmaceutical Group Corporation Information
6.15.2 Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Description and Business Overview
6.15.3 Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Product Portfolio
6.15.5 Shandong Luoxin Pharmaceutical Group Recent Developments/Updates
6.16 Tasly
6.16.1 Tasly Corporation Information
6.16.2 Tasly Valacyclovir Oral Description and Business Overview
6.16.3 Tasly Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Tasly Valacyclovir Oral Product Portfolio
6.16.5 Tasly Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Valacyclovir Oral Industry Chain Analysis
7.2 Valacyclovir Oral Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Valacyclovir Oral Production Mode & Process
7.4 Valacyclovir Oral Sales and Marketing
7.4.1 Valacyclovir Oral Sales Channels
7.4.2 Valacyclovir Oral Distributors
7.5 Valacyclovir Oral Customers
8 Valacyclovir Oral Market Dynamics
8.1 Valacyclovir Oral Industry Trends
8.2 Valacyclovir Oral Market Drivers
8.3 Valacyclovir Oral Market Challenges
8.4 Valacyclovir Oral Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’